This year, Novo Nordisk launched its oral Wegovy pill to kick start the year, while Eli Lilly followed with its own FDA approval for its oral GLP-1 Foundayo (orforglipron) in April
Although this remains speculative, it is conceivable that postprandial hyperglycemia and hyperlipidemia induced by incretin antibodies could also contribute to adverse survival outcomes
While Mounjaro (tirzepatide) is an excellent option for many, we believe in shedding light on alternative medications, ensuring accessibility to the most fitting treatment
GLP-1s serve as one tool within a broader lifestyle framework
Winfrey called fat-shaming one of the last acceptable biases, and McGowan agrees, saying it has devastating implications. Again, the misinformation about why someone is living with obesity comes into play
Compounded medications are self-pay only